Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1970 Feb;45(239):130–133. doi: 10.1136/adc.45.239.130

Dystonic Reactions in Children Caused by Metoclopramide

M Casteels-van Daele, J Jaeken, P Van Der Schueren, A Zimmerman, P Van Den Bon
PMCID: PMC2020385  PMID: 5440179

Abstract

Five cases of alarming dystonic reactions are reported in children receiving a normal dosage of metoclopramide, a new anti-emetic drug. The symptomatology consisted mainly of neck pain, torticollis, retrocollis, oculogyric crisis, and trismus, and patients were admitted with presumed diagnoses of encephalitis, meningitis, and tetanus. After discontinuing the drug, all symptoms disappeared completely.

We believe that metoclopramide should be used with caution in paediatrics and that all doctors should be familiar with its possible bizarre side-effects.

Full text

PDF
130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  2. Bessman S. P. Legislation and advances in medical knowledge--acceleration or inhibition? J Pediatr. 1966 Aug;69(2):334–338. doi: 10.1016/s0022-3476(66)80350-5. [DOI] [PubMed] [Google Scholar]
  3. Birch H. G., Tizard J. The dietary treatment of phenylketonuria: not proven? Dev Med Child Neurol. 1967 Feb;9(1):9–12. doi: 10.1111/j.1469-8749.1967.tb02203.x. [DOI] [PubMed] [Google Scholar]
  4. Boisson J., Albot G. Sur l'intérêt thérapeutique du métoclopramide. A propos de 2 300 observations. Revue critique et indications de son emploi. Cah Coll Med Hop Paris. 1966 Jan;7(1):45–63. [PubMed] [Google Scholar]
  5. Borenstein P., Bles G. Effets cliniques et électroencéphalographiques du métoclopramide en psychiatrie. Therapie. 1965 Jul-Aug;20(4):975–995. [PubMed] [Google Scholar]
  6. Brimblecombe F. S., Blainey J. D., Stoneman M. E., Wood B. S. Dietary and Biochemical Control of Phenylketonuria. Br Med J. 1961 Sep 23;2(5255):793–798. doi: 10.1136/bmj.2.5255.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carpenter G. G., Auerbach V. H., DiGeorge A. M. Phenylalaninemia. Pediatr Clin North Am. 1968 May;15(2):313–323. doi: 10.1016/s0031-3955(16)32124-1. [DOI] [PubMed] [Google Scholar]
  8. Cottom D. G., Newman C. G. Dystonic reactions to phenothiazine derivatives. Arch Dis Child. 1966 Oct;41(219):551–553. doi: 10.1136/adc.41.219.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DODGE P. R., MANCALL E., CRAWFORD J. D., KNAPP J., PAINE R. S. Hypoglycemia complicating treatment of phenylketonuria with a phenylalanine-deficient diet; report of two cases. N Engl J Med. 1959 May 28;260(22):1104–1111. doi: 10.1056/NEJM195905282602202. [DOI] [PubMed] [Google Scholar]
  10. GRIVAUX M., CORNET A., WATTEZ E. LE M'ETOCLOPRAMIDE EN RADIOLOGIE DIGESTIVE. Sem Hop. 1964 Oct 14;40:2338–2345. [PubMed] [Google Scholar]
  11. Gupta J., Lovejoy F. H., Jr Acute phenothiazine toxicity in childhood: a five-year survey. Pediatrics. 1967 May;39(5):771–774. [PubMed] [Google Scholar]
  12. HOLT K. S. Difficulties and dangers in the management of phenylketonuria. Acta Paediatr. 1963 Jul;52:417–423. doi: 10.1111/j.1651-2227.1963.tb03800.x. [DOI] [PubMed] [Google Scholar]
  13. Hackney I. M., Hanley W. B., Davidson W., Lindsao L. Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet. J Pediatr. 1968 May;72(5):646–655. doi: 10.1016/s0022-3476(68)80007-1. [DOI] [PubMed] [Google Scholar]
  14. Hsia D. Y. Phenylketonuria 1967. Dev Med Child Neurol. 1967 Oct;9(5):531–540. doi: 10.1111/j.1469-8749.1967.tb02321.x. [DOI] [PubMed] [Google Scholar]
  15. JUSTIN-BESANCON L., GRIVAUX M., LAVILLE C. TRONC C'ER'EBRAL ET PHYSIOPATHOLOGIE DIGESTIVE. RECHERCHES CLINIQUES ET BIOLOGIQUES. Arch Mal Appar Dig Mal Nutr. 1964 Dec;53:1273–1286. [PubMed] [Google Scholar]
  16. JUSTIN-BESANCON L., LAVILLE C. ACTION ANTI'EM'ETIQUE DU M'ETOCLOPRAMIDE VIS-'A-VIS DE L'APOMORPHINE ET DE L'HYDERGINE. C R Seances Soc Biol Fil. 1964;158:723–727. [PubMed] [Google Scholar]
  17. JUSTIN-BESANCON L., LAVILLE C., THOMINET M. LE M'ETOCLOPRAMIDE ET SES HOMOLOGUES. INTRODUCTION 'A LEUR 'ETUDE BIOLOGIQUE. C R Hebd Seances Acad Sci. 1964 Apr 27;258:4384–4386. [PubMed] [Google Scholar]
  18. Jacoby H. I., Brodie D. A. Gastrointestinal actions of metoclopramide. An experimental study. Gastroenterology. 1967 Apr;52(4):676–684. [PubMed] [Google Scholar]
  19. Rouse B. M. Phenylalanine deficiency syndrome. J Pediatr. 1966 Aug;69(2):246–249. doi: 10.1016/s0022-3476(66)80327-x. [DOI] [PubMed] [Google Scholar]
  20. VIALATTE J., PAUPE J. APPLICATIONS DU M'ETOCLOPRAMIDE AUX VOMISSEMENTS DU NOURRISSON ET DE L'ENFANT. Sem Hop. 1964 Oct 14;40:2367–2373. [PubMed] [Google Scholar]
  21. Witzel K. Extrapyramidal-motorische Störungen bei Kindern als Nebenwirkung der Therapie mit Neuroleptica und dem neuen Antiemeticum Metoclopramid. Arch Kinderheilkd. 1968 Sep;177(3):277–283. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES